Apotex eye drops recalled for lack of sterility assurance
Apotex Corp. is recalling specific lots of brimonidine tartrate/timolol maleate eye drops because the manufacturer cannot confirm the product was sterilized properly. The affected lots are VJ8599 (expires 09/30/2026) and VL1668 (expires 01/31/2027). No infections or injuries have been reported so far.
From the FDA notice · Read the official notice ↗ · All Apotex recalls
What to do
- Check your eye drop bottle for lot number VJ8599 or VL1668
- Do not use the product if it matches either lot number
- Contact your pharmacy or doctor for a replacement prescription
- Call Apotex Corp. at the number on your bottle if you have questions
Is yours affected?
Compare your label or packaging with the recalled product.
- Product
- Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1.
- Sold in
- Nationwide
- Made for
- Adults (0 months and older)
Details
- Units affected
- 107,136 vials
- Illnesses reported
- None reported
- Manufactured in
- 2400 N Commerce Pkwy Ste 400, N/A, Weston, FL, United States
- Classification
- Class II
- Recall number
- D-0407-2026
In the FDA's words
- Description
- Brimonidine Tartrate/Timolol Maleate Ophthalmic Solution 0.2%/0.5%*, 5 mL, Rx Only, Sterile, Apotex Corp. Manufactured for: Apotex Corp., Weston, FL 33326, NDC 60505-0589-1. Lack of Assurance of Sterility Lots VJ8599, Exp Date 09/30/2026 & VL1668, Exp Date 01/31/2027 Distribution: U.S. Nationwide Affected quantity: 107,136 vials
- Hazard
- Lack of Assurance of Sterility
More from Apotex
See all- Apotex paroxetine ER tablets recalled for failed dissolution
ModerateFDAOct 7, 2026
- Paxil CR paroxetine tablets recalled for dissolution test failure
ModerateFDASep 2, 2026